VYX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
VYX is not a good buy right now for an impatient investor. The trend is decisively bearish (SMA200 > SMA20 > SMA5) with a weakening momentum setup (MACD histogram negative and expanding). While RSI (30) hints at short-term oversold conditions, there is no proprietary buy signal (AI Stock Picker or SwingMax) to justify stepping in immediately. With price sitting just above support (9.88) and downside room to the next support (~9.63), the risk/reward for an immediate entry is unfavorable. Best action is to avoid/exit rather than buy now.
Price/Trend: Bearish structure with moving averages stacked negatively (SMA_200 > SMA_20 > SMA_5), indicating a sustained downtrend. Momentum: MACD histogram at -0.0815 (below zero) and negatively expanding suggests downside momentum is strengthening, not stabilizing. RSI: RSI_6 at ~30.1 is near oversold territory, which can trigger bounces, but by itself is not a reliable buy trigger without reversal confirmation. Levels: Pivot 10.287 is overhead (price 9.92 below pivot = bearish). Near-term support S1=9.882 (very close); if it breaks, next support S2=9.632. Resistance levels: R1=10.692 and R2=10.942. Intellectia Proprietary Trading Signals:
Potential technical oversold bounce (RSI near 30).
Options open-interest skew modestly favors calls (OI P/C 0.62).
Upcoming earnings event: QDEC 2025 earnings on 2026-03-02 pre-market (can act as a catalyst if results/guide surprise positively).
and hovering just above key support (9.882); a breakdown opens room toward 9.
Latest reported quarter (2025/Q
showed YoY declines in revenue and a swing to deeper losses (net income and EPS down ~102% YoY), which can keep sentiment pressured.
Latest quarter: 2025/Q3. Revenue: $684M, down -3.80% YoY (top-line contraction). Profitability: Net income -$22M (down -102.04% YoY) and EPS -0.16 (down -102.16% YoY), indicating deterioration versus the prior-year period. Margins: Gross margin improved to 24.27% (+3.94% YoY), a positive efficiency signal, but not enough to offset weaker revenue and losses. Overall: Mixed quality quarter—margin improvement is constructive, but growth and earnings trend are negative.
No analyst rating trend or price target change data was provided, so a clear Wall Street consensus cannot be verified from this dataset. Pros (what analysts would likely like): gross margin improvement and potential operating leverage if revenue stabilizes. Cons (what analysts would likely dislike): declining revenue and a move into deeper losses; current chart setup is technically bearish, which often pressures ratings/targets. Influential trading: Hedge funds and insiders are neutral per the provided trading trends; no recent Congress trading data available in the last 90 days.
